BIOREGENX, INC. Stock-Based Compensation
BIOREGENX, INC. (BRGX) reported Stock-Based Compensation of $6.78 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-05-20
- BIOREGENX, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $6.78K.
- BIOREGENX, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- BIOREGENX, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $0.00.
- BIOREGENX, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- BIOREGENX, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- BIOREGENX, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $2.85M, a 27.37% increase from fiscal 2023.
- BIOREGENX, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $2.24M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $6.78K 10-Q · filed 2026-05-20 | $6.78K derived: sum of 2 quarters · filed 2026-05-20 | $6.78K derived: sum of 3 quarters · filed 2026-05-20 | $6.78K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $0.00 derived: sum of 2 quarters · filed 2026-04-15 | $0.00 derived: sum of 3 quarters · filed 2026-04-15 | $0.00 10-K · filed 2026-04-15 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 | $1.36M derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $1.36M derived: sum of 3 quarters · filed 2026-05-20 | $1.03M derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-20 | $1.36M derived: sum of 2 quarters · filed 2026-05-20 | $1.03M derived: sum of 3 quarters · filed 2026-05-20 | $1.20M derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.03M derived: sum of 2 quarters · filed 2026-04-15 | $1.20M derived: sum of 3 quarters · filed 2026-04-15 | $2.85M 10-K · filed 2026-04-15 |
| 2024-09-30 | -$331.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$158.45K derived: sum of 2 quarters · filed 2025-11-14 | $1.49M 10-Q · filed 2025-11-14 | $3.73M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $172.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.82M 10-Q · filed 2025-08-14 | $4.06M derived: sum of 3 quarters · filed 2025-08-14 | |
| 2024-03-31 | $1.65M 10-Q · filed 2025-05-15 | $3.89M derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $2.24M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-04-16 | $2.24M 10-K/A · filed 2025-04-16 | ||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 |